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Voltage-gated ion channels (VGICs) are membrane proteins that switch from a closed
to open state in response to changes in membrane potential, thus enabling ion fluxes
across the cell membranes. The mechanism that regulate the structural rearrangements
occurring in VGICs in response to changes in membrane potential still remains one of the
most challenging topic of modern biophysics. Na+, Ca2+ and K+ voltage-gated channels
are structurally formed by the assembly of four similar domains, each comprising six
transmembrane segments. Each domain can be divided into two main regions: the
Pore Module (PM) and the Voltage-Sensing Module (VSM). The PM (helices S5 and S6
and intervening linker) is responsible for gate opening and ion selectivity; by contrast,
the VSM, comprising the first four transmembrane helices (S1–S4), undergoes the
first conformational changes in response to membrane voltage variations. In particular,
the S4 segment of each domain, which contains several positively charged residues
interspersed with hydrophobic amino acids, is located within the membrane electric field
and plays an essential role in voltage sensing. In neurons, specific gating properties of
each channel subtype underlie a variety of biological events, ranging from the generation
and propagation of electrical impulses, to the secretion of neurotransmitters and to the
regulation of gene expression. Given the important functional role played by the VSM
in neuronal VGICs, it is not surprising that various VSM mutations affecting the gating
process of these channels are responsible for human diseases, and that compounds
acting on the VSM have emerged as important investigational tools with great therapeutic
potential. In the present review we will briefly describe the most recent discoveries
concerning how the VSM exerts its function, how genetically inherited diseases caused
by mutations occurring in the VSM affects gating in VGICs, and how several classes of
drugs and toxins selectively target the VSM.
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Introduction
Voltage-dependent changes in ion fluxes are critical for the generation and propagation
of electric signals in and between excitable cells. Despite extensive studies performed
during the last 50 years, the mechanisms that regulate the voltage sensitivity of Voltage
Gated Ion Channels (VGICs) still remain one of the most challenging topic of modern
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biophysics. As demonstrated by Hodgkin and Huxley (1952),
voltage sensitivity is regulated by reorientation of charges (or
dipoles) in response to changes in the membrane electric
field. The movement of these charges has been experimentally
demonstrated upon observation of voltage-activated non linear
capacity currents, called gating or sensing currents (Armstrong
and Bezanilla, 1973; Bezanilla et al., 1982).
Although these studies first established the biophysical basis
of voltage-sensing in VGICs, a major breakthrough allowing
to translate into molecular clues such theoretical background
was the cloning and sequencing of the first VGIC, namely
the voltage-gated Na+ channel (VGNC) from the electroplax
of Electrophorus electricus (Noda et al., 1984), followed by the
cloning of the first voltage-gated Ca2+ channel (VGCC) from
rabbit skeletal muscle (Tanabe et al., 1987), and of a voltage-
gated K+ channel (VGKC) from Drosophila (Papazian et al.,
1987).
Subsequent studies using different techniques, including
mutagenesis, fluorescence spectroscopy, and electrophysiology,
have assigned specific functional roles to individual regions of
VGICs; during this structure-function era, the ‘‘modular’’ nature
of this class of membrane proteins was therefore established.
More recently, characterization of the crystal structure of KvAP,
Kv1.2 and chimeric Kv1.2/2.1 K+ channels (Jiang et al., 2003;
Long et al., 2005a,b, 2007) followed by that of the NavAb VGNC
from Arcobacter butzleri (Payandeh et al., 2011) paved the way to
a detailed understanding of the intimate molecular architecture
of VGIC.
In parallel, the extraordinary advancement of sequencing
technologies of the last decade, have allowed the identification of
numerous mutations responsible for human diseases in VGICs
genes, often revealing previously unexplored functional roles
of specific ion channel classes, thereby greatly expanding our
understanding of the pathophysiological mechanisms underlying
human diseases.
Overall Structure of Voltage-Gated Ion
Channels
The VGIC family represents one of the largest group of signal
transduction proteins, also acting as fundamental targets for
drugs with wide therapeutic applications. Primary sequence
analysis indicate VGNCs and VGCCs of eukaryotes are formed
by a single peptide (the α subunit) containing four homologous
domains (called from I to IV). The membrane core of each of
these domains contains six transmembrane helices (from S1 to
S6) with an amphipathic loop between the S5 and S6 segments. By
contrast, VGKCs are formed upon assembly of four compatible
subunits, each showing a high sequence homology with a single
domain of VGNCs or VGCCs (Figure 1). Similarly, bacterial
VGNCs are composed of homotetramers of single domains
whose structure resembles that of each domain of vertebrate
VGNCs (Ren et al., 2001; Koishi et al., 2004), likely being the
evolutionary ancestors of the larger, four-domain Na+ channels
of eukaryotes.
In all VGICs, each structural domain can be divided
into two main regions: the Pore Module (PM) and the
Voltage-Sensing Module (VSM). The PM, which allows selective
permeability of ion species across the cell membrane, is
formed by the fifth and sixth transmembrane segments (S5
and S6, respectively) and the interconnecting loop of all
subunits. The VSM of each domain senses the membrane
potential variations, switching from a resting to an activated
configuration, a necessary prerequisite for subsequent pore
opening; the S1–S4 transmembrane segments play a crucial
role in this process. Both in VGKCs (Long et al., 2007)
as well as in bacterial VGNCs (Payandeh et al., 2011), the
VSM of each domain interacts with the PM of a neighboring
domain, thus allowing movements of the VSM module to be
directly translated into conformational changes of the PM. In
detail, while each of the subunits undergo voltage-dependent
transitions independently (Zagotta et al., 1994), the final voltage-
independent conformational change leading to pore opening
appears to occur in a cooperative, all-or-none fashion (Zandany
et al., 2008), suggesting only two configuration states of the
pore, namely open and closed. However, this binary theory
appears to not exhaustively explain the gating behavior of all
VGICs: as an example, heteromeric pore conformations have
been proposed for Kv2.1 channels, as single-channel analysis
revealed the occurrence of discrete subconductance levels,
possibly resulting from the pore opening of only one or two
subunits (Chapman and VanDongen, 2005). Whether discrete
subconductance states occur and can be detected in all VGICs,
and whether they result from ‘‘partial’’ pore opening, is still
debated.
The VSM is an independent functional module that can be
transplanted into other proteins to confer voltage sensitivity;
indeed, voltage-sensing phosphatases (VSP) are formed by a
VSM linked to a cytoplasmic phosphatase (Murata et al.,
2005; Li et al., 2014c). On the other hand, the VSM can also
allow ion transport by itself; indeed, subunits forming proton-
selective Hv1 channels only contain an isolated VSM, without a
canonical S5–S6 pore region (Ramsey et al., 2006; Sasaki et al.,
2006).
Structural Basis of Ion Permeation and
Inactivation
The PM of VGIC contains the permeation pathway that regulates
ion fluxes and selectivity. Structural information regarding
the molecular mechanisms of ion permeation, selectivity,
and pore opening/closing were obtained from the crystal
structure of bacterial ‘‘inward rectifier’’ K+ channels (KIR)
KcsA (Doyle et al., 1998), MthK (Jiang et al., 2002a,b), and
KirBac1.1 (Kuo et al., 2003), whose membrane core only
contains the regions corresponding to the S5–S6 module.
In these channels, the PM contains a narrow constriction
near its extracellular side, which forms the selectivity filter.
Below this region is a relatively large water-filled cavity at
the center of the plasma membrane. In K+ channels, the
highly conserved GYG sequence forms the selectivity filter
that allows ion discrimination via direct interactions of the
dehydrated K+ ions and the protein backbone carbonyls. While
no eukaryotic VGNC structure is yet available, the crystal
structure of bacterial NavAb, recently described at 2.7 Å of
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FIGURE 1 | Topological representation of voltage-gated K+ (Kv),
Na+ (Nav) and Ca2+ (Cav) channels with related neuronal diseases.
Nav channels are formed by a single polypeptide that contains four
domains (I-IV), each with six transmembrane segments (S1–S6).
β-subunits are single transmembrane proteins that co-assembles with the
Nav α-subunit. Cav channels show a similar topology to Nav channels in
their α-subunits, but can be associated with four different auxiliary
subunits: the α2/δ-complex, linked by disulfide bridges, an intracellular
β-subunit, and an occasional γ-subunit with four transmembrane
segments. Abbreviations: GEFS+, Generalized Epilepsy with Febrile
Seizures plus; SMEI, Severe Myoclonic Epilepsy of Infancy; FHM1-3,
Familial Hemiplegic Migraine type 1-3, respectively; BFNS, Benign Familial
Neonatal Seizures; BFNIS, Benign Familial Neonatal-Infantile Seizures; EE,
Epileptic Encephalopathy; PE, Primary Erythermalgia; PEPD, Paroxysmal
Extreme Pain Disorder; CIP, Congenital Insensitivity to Pain; FEPS2-3,
Familial Episodic Pain Syndrome type 2-3, respectively; HSAN7,
Hereditary Sensory and Autonomic Neuropathy type 7; EA1-2, Episodic
Ataxia type 1-2, respectively; SCA6-13, Spinocerebellar Ataxia type 6-13,
respectively; PME, Progressive Myoclonus Epilepsy; CDSRR, Cone
Dystrophy with Supernormal Rod Electroretinogram.
resolution (Payandeh et al., 2011), have revealed that a similar
region is involved in ion discrimination, although Na+ ions
permeate in their partially hydrated configuration across a
wider selectivity filter. This region is likely to mediate ion
discrimination also in VGNCs and VGCCs of vertebrates; in
fact, it has been long known that substitution of positively
charged amino acids in the PM of rat Nav1.2 with glutamic
acid residues (which occupy equivalent positions in VGCCs),
enhances Ca2+ ion permeability (Heinemann et al., 1992).
In both VGNCs and VGCCs, a second pore-helix forms an
extracellular funnel, a unique feature that could represent a
conserved structural element in the outer vestibule of these
channels.
Comparing the structural data of KcsA and KirBac1.1
channels, trapped in a closed conformation, with that of
MthK channels, trapped in an open conformation, it has been
possible to deduce structural changes that underlie pore opening
in K+ channels. In KcsA and KirBac1.1 channels, the M2
segments, corresponding to the S6 segments in VGIC, form
a four-helix bundle near the intracellular membrane surface
that occludes the ion conduction pathway; whereas, in MthK
channels the inner region of M2 is bent at a glycine residue;
this residue is highly conserved among bacterial K+ channels
and in some eukaryotic VGKCs. This glycine residue has
been proposed to serve as a gating hinge that allows M2
to oscillate between a close and an open conformation. In
eukaryotic K+ channels, it has been proposed that a conserved
PVP (Proline-Valine-Proline) motif, not found in bacterial K+
channels and located in S6 downstream of the glycine residue,
acts as a flexible hinge that allows channel switching from
a closed to an open state (Webster et al., 2004; Long et al.,
2005a,b). In particular, this inner part of the S6 segment, also
called ‘‘bundle crossing’’ (BC) gate, appears to come close to
the S4–S5 linker during channel activation, thus allowing to
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‘‘sense’’ VSM movement (Prole and Yellen, 2006); BC gate
widening prompts a conformational change in a further gate
located at the extracellular entrance of the pore, called the
‘‘selectivity filter’’ gate, leading to pore opening (Labro and
Snyders, 2012). The differences in single channel conductance
observed between bacterial and mammalian channels might
be explained by different degree of movement of the distal
S6 regions; indeed, movements seem much wider in bacterial
(having larger single channel conductance) when compared to
mammalian channels, the latter having a 10-times smaller single
channel conductance.
In some VGICs, currents show prominent inactivation
following activation. Two main types of inactivation have been
described in VGKCs: the N-type and the C-type inactivation.
The N-type inactivation, which is usually more rapid than the
C-type, occurs by a ball peptide tethered to the N-terminus
of the channels that enters into the pore cavity blocking ion
flow (Hoshi et al., 1990). By contrast, the C-type inactivation
gate is located in the selectivity filter, and current inactivation
is due to the pore collapse (Cuello et al., 2010a,b); structural
data from bacterial KCsA confirm such a hypothesis (Bhate
and McDermott, 2012). In VGNCs of vertebrates, the short
intracellular loop between domains III and IV is responsible
for fast inactivation by folding into the intracellular mouth
of the pore and blocking it (Vassilev et al., 1988). In
particular, the amino acid motif isoleucine, phenylalanine,
and methionine (IFM) is required to stabilize the inactivated
state of the channels (West et al., 1992). Finally, inactivation
processes in VGCCs are more complex, including both voltage-
and/or calcium-dependent mechanisms (Simms and Zamponi,
2014).
Structural Basis of Voltage-Sensing
As above mentioned, voltage-sensitivity of VGICs is conferred
by the VSM. In particular, the S4 segments are believed to play
a key role in the voltage-sensitivity. Indeed, S4 primary sequence
shows the presence of 4–8 positively-charged arginines (Rs) or
lysine (Ks) residues separated by 2–3 uncharged residues; this
configuration would allow positive charges to be localized on
the same side of an α-helix. These basic residues are located
within the electrical field existing across the two sides of the
plasma membrane, thus directly sensing changes in membrane
potential. The first four Rs in S4 are considered the most
important voltage-sensing elements and are believed to be the
major component of gating currents (Aggarwal and MacKinnon,
1996; Seoh et al., 1996). In Kv1.1 channels, it has been calculated
that approximately 13 elementary charges cross the electric
field in response to membrane depolarization, corresponding
to about three elementary charges per subunit (Schoppa et al.,
1992).
The molecular mechanisms underlying VSM movement
during gating are highly debated topics; nevertheless, results
obtained withmolecular, biochemical, electrophysiological, optic
and crystallographic techniques have enormously expanded our
knowledge in this field. In particular, the crystal structures
of bacterial KvAP (Jiang et al., 2003), followed by that of
mammalian Kv1.2 and Kv1.2/2.1 chimeric VGKCs (Long et al.,
2005a, 2007), provide important information on the activated
configurations of the VSM. Although no crystal structure is
available for the resting state of the VSM, several hypotheses
(helical-screw/sliding-helix, transporter and paddle models; see
Tombola et al., 2006; Catterall, 2010; Miceli et al., 2011 for
reviews) have been formulated to explain how the voltage
sensor reaches its activated configuration during channel gating.
Currently, these models converge toward an unified hypothesis
(Khalili-Araghi et al., 2010; Vargas et al., 2011; Jensen et al.,
2012; Yarov-Yarovoy et al., 2012), in which the resting and
activated positions of the VSM would be stabilized by ionized
hydrogen bonds between the S4 positive charges and two clusters
of negative charges: one facing the extracellular side of the
membrane and provided by the S1 and S2 helices, and another
closer to the intracellular membrane surface, involving S2 and
the proximal part of S3 (S3a) helices. At rest, S4 is drawn
inwardly by the electrostatic forces of the negative resting
membrane potential (RMP); this would allow the first S4 Rs
(gating charges) to preferentially interact with the inner cluster of
negative charges. During the activation process, S4 would rotate
around its helical axis and translate outwardly, reaching a final
configuration stabilized by the interaction of the same positively-
charged residues with the negative charges provided by the
extracellular cluster. This relatively small movement would allow
the displacement of the gating charges from an intracellular-
facing crevice to one directly connected to the extracellular
milieu. A conserved phenylalanine located in the middle of
S2 has been proposed to form the charge-transfer center that
catalyzes the gating charges movement (Tao et al., 2010) and
separates the extracellular and the intracellular crevices of
the VSM.
In several VGKCs including Kv1.1, the replacement of specific
Rs in S4 with smaller amino acids widens this gating charge
pathway, generating cation-permeable non-selective currents
(also known as gating pore currents, orω currents). Interestingly,
gating-pore currents generated by mutations in S4 of Nav1.4
or Cav1.1 channels seem to provide a pathophysiological-
relevant mechanism in hypokalemic (Sokolov et al., 2007;
Struyk and Cannon, 2007) or normokalemic (Sokolov et al.,
2008) periodic paralysis in skeletal muscle. Similar mechanisms
seem implicated in a mixed arrhythmias and the dilated
cardiomyopathy caused by the R219H mutation in domain
I of Nav1.5, which induces a proton-specific gating pore
current (Gosselin-Badaroudine et al., 2012), and in peripheral
nerve hyperexcitability caused by the R207Q in Kv7.2 channels
(Miceli et al., 2012). Noteworthy, sequence analysis has revealed
that several other channelopathies (including some affecting
neuronal channels) might be attributable to the formation
of gating pore currents, however more studies are required
to confirm the presence of gating pores (Moreau et al.,
2014).
Structural Basis of Electromechanical Coupling
Electromechanical coupling describes the process of transferring
the energy generated by the VSM movement upon changes
in membrane potential to the PM. To simplify a complex
process, at resting state the S4–S5 linker directly interacts with
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the distal part of S6, making the BC gate the main voltage-
controllable activation gate. Upon depolarization, S4 movement
pulls the S4–S5 linker outwardly leading to a widening of
the helical BC gate, which triggers a further conformational
change at the level of the selectivity filter (SF) gate that allows
ions flow through the pore. The crystal structures of Kv1.2
and of chimeric Kv1.2/2.1 channels suggest at least two non-
covalent interactions between VSM and PM: one between the
S4–S5 linker and the distal S6 segment at the cytoplasmic
side of the membrane, and the other between the C-terminal
region of S1 and the C-terminal region of S5 at extracellular
site of the membrane (Lu et al., 2002; Long et al., 2005b,
2007). The interaction between S4–S5 linker and the bottom
part of S6 seems to play an important role for transmission
of conformational changes during channel gating; while the
interaction between S1 and S5 acts as an anchor point between
the VSM and the PM, thus allowing efficient transmission of
conformational changes to the pore’s gate (Lee et al., 2009). Other
interactions between VSM and PM include: the bottom part
of S4 with S5 segments of neighboring subunits (Soler-Llavina
et al., 2006) and the upper part of S5 with the upper part of
S4 of the neighboring subunit (Lainé et al., 2003). Based on the
available molecular dynamic simulations and experimental data,
Blunck and Batulan (2012) proposed two different mechanisms
to describe the electromechanical coupling in Shaker-like Kv
channels. In one model S4 and S4–S5 linker act as a spring
that is relaxed or compressed by the activation/deactivation
of the VSM. In the second model, S4 and S4–S5 linker act
as a bolt that keeps the pore closed; only when all four
S4–S5 linkers have moved out the pore passively follows the
opening.
The general mechanism of the electromechanical coupling
seems to be conserved among the different K+ channels,
although changes in the type of interactions and in the tightness
of the coupling may occur in specific channels. Moreover, this
general mechanism also seems to apply to skeletal VGNCs
(Muroi et al., 2010) and VGCCs (Wall-Lacelle et al., 2011). By
contrast, in hyperpolarization-activated cyclic nucleotide gated
channels (HCN) decoupling between VSM and PM triggers pore
closure (Blunck and Batulan, 2012).
Neuronal Channelopathies Caused by
Mutations in the VSM
Potassium Channelopathies
Structure and Function of Voltage-Gated Potassium
Channels (VGKCs)
K+ channels are the largest and the most functionally
heterogeneous class of ion channels expressed in all eukaryotic
cells and in prokaryotes. K+ channels mostly inhibit neuronal
excitability by setting the membrane potential closer to the
K+ equilibrium potential. Moreover, activation of K+ channels
shortens the duration of the action potential (AP), terminates
periods of intense electrical activity, reduces neuronal firing
frequency, and, in general terms, decreases the efficacy of cell
excitatory inputs. Beside these roles, K+ channels participate
in solute transport across epithelial membranes, and K+
clearance from brain interstitial spaces from glial cells. In
humans, more than 70 genes encode for K+ channels. On
the basis of their presumed topology, K+ channels can be
classified into three groups: (1) the classical family with 6
transmembrane segments (6TM) including the voltage-gated
K+ channels (Kv channels; Kv1-Kv12; Figure 1); (2) a family
with only 2 transmembrane segment (2TM), homologous to
the S5–S6 segments of Kv channels. To this group belong
the inward-rectifier channels (both constitutively-active and
G-protein-gated), which include at least seven gene families
(KIR1-KIR7); (3) the 4 transmembrane segment family (4TM),
formed by subunits encoded by at least 15 different genes
(K2P1-K2P17; Yu et al., 2005). While channels formed by
subunits of the first two groups are tetrameric, those of
the third group are dimers. However, these three groups
do not account for all K+ channel structural heterogeneity;
in fact, large conductance Ca2+-dependent K+ channels (BK
channels) assemble as tetramers of subunits containing seven
transmembrane segments, which differ from Kv subunits for the
presence of an extra transmembrane segment (S0) at the N-
terminus.
Several VGKCs interact with accessory β-subunits that
influence a wide range of channel properties such as gating,
assembly, trafficking, and targeting of channels to different
cellular compartments. Accessory VGKC subunits include
different protein structures reflecting their divergent biological
roles. Indeed, some β-subunits are integral membrane proteins
such as β-subunits of both BK and Kv7 channels; while, others
are cytosolic proteins and bind to cytoplasmic modules of VGKC
such as Kvβ-subunits for Shaker Kv channels and KChIPs for Kv4
channels (Pongs and Schwarz, 2010 for review).
Kv1.1 (KCNA1) and Kv1.2 (KCNA2) Channel Mutations
Cause Episodic Ataxia Type 1 (EA1) or Epileptic
Encephalopathy (EE), Respectively
Kv1.1 and Kv1.2 subunits, belonging to the Kv1 family of VGKCs,
generate delayed rectifier channels active at or below the RMP,
with fast activation/deactivation kinetics and slow inactivation,
mainly contributing to transient, slowly inactivating current (ID).
Kv1 family members are expressed throughout many regions
of the central nervous system (CNS), including hippocampus,
cerebellum, and brainstem nuclei. In several brain regions,
co-assembling of Kv1.1 with Kv1.4 subunits, which contain
N-terminal Inactivation Modules, confers N-type inactivating
properties to heteromeric channels. At neuronal subcellular level,
Kv1.1, Kv1.2 and Kv1.4 are expressed in the axon initial segment
(AIS) where they control AP threshold and firing (Figure 2),
in juxtaparanodal regions next to Ranvier’s nodes, in synaptic
terminals and in proximal dendrites (Trimmer and Rhodes,
2004). The important pathophysiological role of Kv1.1 channels
is underlined by the occurrence of mutations in this channel
in patients affected with Episodic Ataxia type 1 [EA1; Online
Mendelian Inheritance in Man (OMIM) 160120]. EA1 is a
rare, disabling condition with autosomal-dominant inheritance
characterized by constant myokymia and dramatic episodes of
spastic contractions of head, arms and leg muscles, together
with the loss of motor coordination and balance. Moreover,
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FIGURE 2 | Contribution of K+ currents during AP firing. Representation
of the different K+ channel subtypes activated during an AP. The inset shows
the effect of Kv7 channel activation during AP firing (modified from Tsantoulas
and McMahon, 2014).
EA1 is associated with an increased incidence of epilepsy. Other
features include delayedmotor development, cognitive disability,
choreoathetosis, and carpal spasms. Disease onset is in childhood
or early adolescence (D’Adamo et al., 2014). An altered function
of Kv1.1 channels expressed in the cerebellummay be responsible
for ataxia, whereas seizures and cognitive dysfunctions associated
with EA1 may be caused by impaired Kv1.1 channels in the
hippocampus. The first description of a family affected by
EA1 was in 1975 (VanDyke et al., 1975); subsequent genetic
analysis revealed a heterozygous point mutation in the coding
sequence of the human gene KCNA1, encoding for Kv1.1
channels, leading to the F184C substitution in the S1 segment.
Electrophysiological studies demonstrated that this mutation
shifts the activation curves of Kv1.1 channels to more positive
voltages, therefore leading to loss-of-function effects (Adelman
et al., 1995). Several other Kv1.1 mutations causing EA1 have
been described and they appear to be localized in relevant
functional regions of the channels, particularly in the VSM
(Figure 3) or in the PM. Overall, functional studies performed on
numerous mutant channels revealed that EA1-causingmutations
may alter membrane expression or gating processes, such as
opening and closure kinetics, voltage-dependence of activation,
N- and C-type inactivation. An atypical mechanism by which
the V408A pore-mutation affects gating of Kv1.1 channel
has been described by means of voltage-clamp fluorometry
and single-channel recordings. This mutation accelerates the
outward current decay during depolarization by promoting an
‘‘activated-not-open’’ conformation rather than by increasing
C-type inactivation (Peters et al., 2011). Moreover, mutations
within the VSM cause EA1 mainly by a reduction of maximal
currents, in some cases with dominant-negative effects (as in
the case of R167M, C185W, F249I, I262T or R307C mutations;
Adelman et al., 1995; Zerr et al., 1998; Graves et al., 2010; Zhu
et al., 2012; Tomlinson et al., 2013). These results suggest that
EA1-causing mutations induce loss-of-function effects on Kv1.1
channels, with haploinsufficiency appearing as the most likely
pathogenetic mechanism for the disease. Accordingly, the loss
of Kv1.1 channels, obtained either by genetic or pharmacological
manipulations, caused alterations in the hippocampal network,
which showed more frequent and longer spontaneous sharp
waves and high frequency oscillations; moreover, in the CA3
region from Kv1.1−/− mice, mossy fibers and medial perforant
path axons were hyperexcitable and produce greater pre- and
post-synaptic responses, also showing a reduced paired-pulse
ratios suggestive of an increased neurotransmitter release at these
terminals (Simeone et al., 2013).
More recently, four different de novo mutations in the
KCNA2 gene, encoding for Kv1.2 K+ channel subunits, have
been identified in patients with Epileptic Encephalopathy (EE).
Three of these mutations affect conserved residues in the VSM
(I263T in S3, R297Q and L298F in S4) and one in the PM
(P405L). Functional studies in heterologous expression systems
revealed that channels formed by subunits carrying the I263T
or P405L mutations almost completely lost their function,
with also dominant-negative effects on wild-type channels; by
contrast, the two S4 mutations caused a gain of function effect
(Syrbe et al., 2015). A Kv1.2 mutation has been also described
in a mouse model of cerebral ataxia (I402T substitution in
the S6 segment), called Pingu: patch-clamp recordings from
cerebellar slices revealed an increased frequency and amplitude
of spontaneous GABAergic inhibitory postsynaptic currents and
reduced AP firing frequency in Purkinje cells, suggesting that
Kv1.2mutation-dependent increase in GABA release from basket
cells is involved in the loss of motor coordination in Pingu mice
(Xie et al., 2010).
Kv3.1 (KCNC1) and Kv3.3 (KCNC3) Channel Mutations
Cause Progressive Myoclonus Epilepsy (PME) or
Spinocerebellar Ataxia Type 13 (SCA13), Respectively
The Kv3 family of VGKCs comprises four members (from
Kv3.1 to Kv3.4, encoded by the KCNC1-KCNC4 genes) that
differ from others VGKCs because of a more positive activation
threshold (thus, they are identified as ‘‘high-threshold channels’’)
and their fast rate of deactivation upon repolarization. These
unique properties specifically enable AP fast repolarization
without affecting spike initiation and AP duration (Rudy and
McBain, 2001; Figure 2). The expression of Kv3.1, Kv3.2
and Kv3.3 is limited to the CNS, whereas Kv3.4 is mainly
expressed in skeletal muscles and sympathetic neurons, and
only weakly expressed in a few neuronal types. In the CNS,
Kv3 channels are mainly expressed in fast-spiking neurons, such
as GABAergic interneurons. Accordingly, suppression of Kv3
currents by pharmacological tools (Erisir et al., 1999) or in
knockout mice (Lau et al., 2000) impairs firing properties of
fast-spiking neurons, affects neurotransmitter release (Sabatini
and Regehr, 1997), and induces cell death (Irie et al.,
2014).
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FIGURE 3 | Alignment of the VSM of different Kv, Nav and Cav
channel subtypes. The VSM have been aligned by using ClustalW2
software; highlighted in yellow are the missense mutations causing EA1
(in Kv1.1); PME (in Kv3.1); SCA13 (in Kv3.3); BFNS (in Kv7.2 and Kv7.3);
EEIE7 (in Kv7.2); RCD3B (in Kv8.2); FHM3, SMEI, and GEFS+ (in
Nav1.1); and FHM1, EA2 and SCA6 (in Cav2.1). Mutations in SCN1A are
from a database available at http://www.molgen.ua.ac.be/SCN1A
Mutations/home/Default.cfm.
Spinocerebellar Ataxias (SCAs) are a very heterogeneous
group of autosomal dominant neurological disorders caused
by degeneration of the cerebellum and spinal cord. SCAs
show a wide range of phenotypes, including cerebellar ataxia,
dysarthria, extrapyramidal symptoms, oculomotor disturbance,
cognitive impairment, and epilepsy. Most SCAs are caused
by trinucleotide repeat expansions, while other forms are
caused by point mutations in protein kinases, cytoskeletal and
mitochondrial proteins, and proteins regulating intracellular
calcium stores, such as beta 3 Spectrin (SPTBN2), Tau Tubulin
Kinase 2 (TTBK2), Protein Kinase C Gamma type (PRKCG),
Inositol 1,4,5-Trisphosphate Receptor type 1 (ITPR1), ATPase
Family Gene 3 Like 2 (AFG3L2). In particular, SCA13 (OMIM
605259) is caused by point mutations in the KCNC3 gene,
encoding for Kv3.3 channels. So far, three mutations have been
identified in Kv3.3, two of which affect residues in the VSM
(R420H and R423H both in S4; Figure 3) and one in the PM
(F448L; Waters et al., 2006; Figueroa et al., 2010). Functional
studies performed in heterologous expression systems revealed
that both VSM mutations caused a complete abolishment
of channel function when expressed homomerically, whereas
the co-expression of mutant subunits with wild-type subunits
caused a significant suppression of Kv3.3 activity, consistent
with dominant-negative effects. By contrast, the pore mutant
F448L channels did not affect current amplitude, but causes a
hyperpolarization shift of the current activation and slows the
rate of deactivation, suggesting that this mutation increases the
stability of the open state (Waters et al., 2006). Taken together,
these data suggest that mutations in KCNC3 may cause SCA
both by gain- and loss-of-function mechanisms (Figueroa et al.,
2010).
More recently, a recurrent mutation in the KCNC1 gene,
encoding for Kv3.1 channels, has been identified in patients
with Progressive Myoclonus Epilepsy (PME7; OMIM 616187;
Muona et al., 2015), one of the most devastating form of
epilepsy, characterized by a very wide clinical and genetic
heterogeneity (Berkovic et al., 1986). Most of PME cases are
autosomal recessive, although in few cases an autosomal dominat
transmission occurs. Clinically, the most common features of
this disease are myoclonus, tonic-clonic seizures and progressive
neurological decline. The mutation occurring in Kv3.1 channel
causing PME affects a highly conserved residue in the S4 segment
(R320H; Figure 3). Functional experiments in heterologous
expression systems showed that the R320H substitution caused
a prominent loss of function, with dominant-negative effects on
wild-type Kv3.1 channels.
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Kv7.2/7.3 (KCNQ2/KCNQ3) and Benign Familial
Neonatal Seizures (BFNS)/Epileptic Encephalopathy
(EE)
Kv7.2 and Kv7.3 channels belong to the KCNQ gene family
that comprises five members (KCNQ1-5) encoding for K+
channel subunits showing different tissue distribution and
physiological roles (Soldovieri et al., 2011). When heterologously
expressed, homomeric Kv7.2 channels generate K+-selective
currents activated by depolarization at membrane potentials
around −50 mV with slow activation and deactivation kinetics
and lacking significant inactivation. Currents carried by Kv7.3
homomultimers are rather small and activate around −60
mV; among Kv7 members, Kv7.3 channels show the highest
opening probability and unitary conductance at the single-
channel level (Li et al., 2005). Co-expression of Kv7.2 and Kv7.3
channels generate currents 10-times larger than those obtained
by the simple sum of the currents produced by Kv7.2 or Kv7.3
homomultimers (Wang et al., 1998; Yang et al., 1998). This
effect is mainly mediated by a higher opening probability of
Kv7.2/Kv7.3 heteromers compared to Kv7.2 homomers, together
with a two- to threefold increase in the number of channel-
forming subunits expressed at the plasma membrane (Schwake
et al., 2000). In the brain, heteromeric assembly of Kv7.2
and Kv7.3 subunits underlies the M-current (IKM), a slowly
activating and deactivating K+ current that regulates neuronal
excitability in the sub-threshold range for AP generation
(Soldovieri et al., 2011; Figure 2). Mutations in KCNQ2 (Kv7.2)
and KCNQ3 (Kv7.3) genes are responsible for neonatal-onset
epileptic diseases with widely-diverging clinical manifestations,
ranging from benign to very dramatic phenotypes. Indeed,
mutations in these two genes have been identified in patients
affected with Benign Familial Neonatal Seizures (BFNS1; OMIM
121200), an autosomal dominant epilepsy of newborns (Biervert
et al., 1998; Charlier et al., 1998; Singh et al., 1998), characterized
by recurrent seizures that begin in the first days of life
and remit after a few weeks or months, with mostly normal
interictal EEG, neuroimaging, and psychomotor development
(Bellini et al., 2010). In addition, de novo missense Kv7.2
mutations have been recently found in neonates affected with
pharmacoresistant seizures, distinct EEG and neuroradiological
features, and various degrees of developmental delay, defining
a ‘‘Kv7.2 encephalopathy’’ (Weckhuysen et al., 2012; EIEE7;
OMIM613720). Subsequently, de novomissense Kv7.2mutations
have been also shown as one of the most common cause of
early-onset EEs, including the Ohtahara syndrome (Saitsu et al.,
2012; Kato et al., 2013), the most severe and earliest developing
age-related EE. Most disease-causing Kv7.2 mutations cluster
in the VSM (Figure 3), in the PM or in the long C-terminus
of the channel. Functional studies for a significant fraction
of the described Kv7.2 or Kv7.3 mutations have been carried
out, with consequences ranging from slight changes in channel
behavior to a complete ablation of channel function (Castaldo
et al., 2002; Soldovieri et al., 2006; Miceli et al., 2009). A slight
(about 25%) decrease of IKM is believed to be sufficient to
cause BFNS, and haploinsufficiency seems to be the primary
pathogenetic mechanism for BFNS. Moreover, two independent
studies suggested that the clinical disease severity may be
related to the extent of mutation-induced functional K+ channel
impairment (Miceli et al., 2013; Orhan et al., 2014).
BFNS-causing mutations have been also found to neutralize
some of the positively-charged residues in the S4 segment
(R207W, R213W, or R214W; Miceli et al., 2008; Bellini
et al., 2010): the functional characterization of Kv7.2 channels
carrying each of these mutations suggests a reduced channel
sensitivity to depolarization; accordingly, homology model of
Kv7.2 based on the crystal structure of Kv1.2/Kv2.1 chimeric
channels revealed that these residues form intrasubunit ionized
hydrogen bonds with negatively-charged residues present in
the outer cluster which stabilize the activated state of the
voltage sensor. Thus, it seems plausible to hypothesize that
in mutant channels the activated configuration of the VSM
is destabilized, explaining the positive shift in steady-state
voltage dependence of activations and possibly the neuronal
hyperexcitability in individuals carrying these mutations (Miceli
et al., 2008, 2013).
Notably, although most epilepsy-causing mutations in Kv7.2
or Kv7.3 so far indentified induced loss-of-function effects,
electrophysiological experiments performed on Kv7 channels
carrying de novo mutations recently found in individuals
affected with various forms of early-onset EEs (R144Q, R201C,
or R201H in Kv7.2, and R230C in Kv7.3; Rauch et al.,
2012; Allen et al., 2013; Carvill et al., 2013; Weckhuysen
et al., 2013) have demonstrated that all four mutations cause
hyperpolarization shifts of the current activation process by
destabilizing the resting state of the VSM (Miceli et al.,
2015). Accordingly, computational modeling of a feedforward
inhibitory microcircuit formed by a principal hyppocampal CA1
neuron and an inhibitory interneuron suggest that a gain-of-
function mutation in Kv7.2/3-IKM can increase the (apparent)
excitability of hippocampal CA1 pyramidal neurons by selective
suppression of interneuron activity. These data suggest that
Kv7.2/3 mutations may cause human epilepsy by both loss-of-
function and gain-of function mechanisms; whether these two
mechanisms underlie different clinical entities (in terms of age
of onset, severity, prognosis, and pharmacosensitivity) is yet
unknown.
Kv8.2 (KCNV2) Mutations Cause Cone Dystrophy with
Supernormal Rod Electroretinogram (CDSRR) or
Epilepsy
Kv8.2 subunits are structurally similar to others VGKCs,
although they do not form functional channels in homomeric
configuration: for this reason, they are also called ‘‘silent
modulators’’. Conversely, they are functional upon assembly
in heteromeric channels with other subunits (e.g., Kv2). The
KCNV2 gene encoding for Kv8.2 subunits was first cloned
from human testis cDNA, but its expression has been also
detected in other tissues, such as the photoreceptor layer of
the human retina (Wu et al., 2006) and in the hippocampus,
where it co-localizes with Kv2.1 (Allen Institute for Brain
Science1), the major contributor for delayed rectifier K+ currents
in neurons (Murakoshi and Trimmer, 1999). Co-assembling
1http://mouse.brain-map.org
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of silent Kv8.2 with Kv2.1 subunits causes a decrease in the
maximal currents as well as modifications in the activation,
inactivation, and deactivation kinetics (Bocksteins and Snyders,
2012). Mutations in Kv8.2 channels, some of them located within
the VSM (Figure 3), cause cone dystrophy with supernormal
rod response (RCD3B; OMIM 610356), a very rare autosomal
recessive retinal disorder, characterized by reduced visual acuity,
photoaversion, night blindness, and abnormal color vision.
At an early age, the retina shows subtle depigmentation
of the macula and, later, more obvious areas of atrophy.
Electroretinographic features are characteristic and essential for
diagnostic purposes. In addition to RCD3B, two mutations
in Kv8.2 channels have been identified in two unrelated
children affected by epilepsy: one mutation is located in the N-
terminal region (R7K), and the other in the S1 segment of the
VSM (M285R; Figure 3). Functional studies demonstrated that
both mutant channels increased Kv8.2-mediated suppression of
Kv2.1 currents. Moreover, heteromeric channels incorporating
M285R mutant subunits exhibited additional gating defects,
including a +10 mV shift in the voltage dependence of
activation and slower activation kinetics. Taken together, these
data suggest that both variants may decrease delayed rectifier
K+ currents in neurons, possibly leading to an increased
excitability under conditions of repetitive stimulation (Jorge
et al., 2011).
Kv10.2 (KCNH5) and Epileptic Encephalopathy (EE)
The KCNH5 gene encodes for Kv10.1 potassium channels
belonging to the ether-a-go-go (EAG) family (Saganich et al.,
1999). EAG family comprises two channel subtypes (Kv10.1 and
Kv10.2), that are over-expressed in cancer cells (Camacho, 2006).
Kv10.2 is also expressed in the CNS (Saganich et al., 1999),
although its function is still unclear (Wulff et al., 2009). Recently,
by using whole-exome sequencing in children with sporadic
cases of EE of unknown etiology, a novel variant in KCNH5
has been identified (R327H in S4). Structural and functional
analysis showed that this pathogenic variant destabilized the
resting state of the VSM, therefore leading to a hyperpolarizing
shift of the activation curve, suggesting a gain-of-function
pathogenetic mechanism associated to this mutation (Yang et al.,
2013).
KCa4.1 (KCNT1) Mutations Cause Malignant Migrating
Partial Seizures of Infancy (MMPSI) and Autosomal
Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
The KCNT1 gene encodes for KCa4.1, a sodium-activated
potassium channel, also known as ‘‘sequence like a calcium
activated potassium channel’’ (Slack) or Slo2.2. Structurally, this
channel is similar to the classic VGKCs except for two properties:
no charged residues in S4 and a very large cytoplasmic C-terminal
region. KCa4.1 is highly expressed in different regions of the
mammalian brain where it generates a delayed outward current
termed IKNa that regulates neuronal excitability. Mutations
in KCNT1 gene have been identified in patients with two
different type of epilepsy occurring in infancy or childhood:
Malignant Migrating Partial Seizures of Infancy (MMPSI; also
called Epilepsy of Infancy with Migrating Focal Seizures, EIMFS)
and Autosomal Dominant Nocturnal Frontal Lobe Epilepsy
(ADNFLE; Barcia et al., 2012; Heron et al., 2012). MMPSI is
a severe early onset epileptic encephalopathy beginning before
of 6 months of age. It is characterized by heterogeneous focal
seizures, with seizures foci migrating from one brain region and
hemisphere to another, and is associated with arrest or regression
of development, resulting in profound disability. By contrast,
ADNFLE is characterized by nocturnal frontal lobe seizures
beginning in mid childhood, with psychiatric, behavioral, and
cognitive disabilities in some cases. All the described mutations
causing MMPSI and ADNFLE are not located into the VSM;
however, they dramatically affect channel function, with a
striking gain-of-function phenotype in vitro (Milligan et al.,
2014).
Sodium Channelopathies
Structure and Function of Voltage-Gated Sodium
Channels (VGNCs)
VGNCs contribute to the generation of both somatodendritic
and axonal AP and conduct subthreshold persistent Na+
currents following AP. Structurally, they are complexes of a pore-
forming α subunit of 260 kDa, associated to auxiliary β subunits
(β1–β4) of 33-36 kDa (Figure 1; Catterall, 2000). Auxiliary
β subunits can assemble with α-subunits and modify their
subcellular localization and biophysical properties. In particular,
β2 and β4 subunits form disulfide bonds with α subunits,
whereas β1 and β3 subunits interact with α-subunits non
covalently. Structurally, β subunits are formed by an N-terminal
extracellular immunoglobulin-like fold, a single transmembrane
α-helix and a short intracellular segment (Isom et al., 1992, 1995).
Each α subunit contains four internally repeated domains
(called from DI to DIV), each including a VSM and a PM.
In the VSM, S4 segments in all four domains have previously-
described primary sequence and functional role (Catterall, 1986;
Guy and Seetharamulu, 1986; Yarov-Yarovoy et al., 2006, 2012).
Furthermore, the DIII-DIV linker and particularly the key IFM
motif, plays a crucial role in channel fast inactivation, a process
that contributes to the neuronal excitability control.
In humans, 10 genes encode for VGNC α subunits; these
are expressed in different excitable tissues and give rise to
currents with peculiar biophysical properties (Goldin, 2001).
Nav1.1, Nav1.2, Nav1.3 and Nav1.6 channel subtypes are
the primary Na+ channels in the CNS; by contrast, Nav1.7,
Nav1.8 and Nav1.9 channel subtypes are mainly expressed
in the peripheral nervous system (PNS); finally, Nav1.4
channels are expressed in skeletal muscle and Nav1.5 in
the heart. The tenth sodium channel protein (Nav1.10) is
not voltage-gated and is involved in salt sensing (Watanabe
et al., 2000). At the subcellular level, Nav1.1 and Nav1.3
channels are primarily localized in cell bodies (Westenbroek
et al., 1989, 1992), whereas Nav1.2 channels are positioned
in unmyelinated or pre-myelinated axons and dendrites, and
Nav1.6 channels in myelinated axons and dendrites (Caldwell
et al., 2000). In the developing neocortex, Nav1.1 channels
appear to be abundantly expressed in the proximal part
of the AIS of parvalbumin- (Ogiwara et al., 2007; Li et al.,
2014b) and, at lower levels, somatostatin-positive GABAergic
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interneurons (Li et al., 2014b). By contrast, in the same
region, Nav1.2 channels are preferentially distributed to the
somatostatin-positive population of GABAergic neurons,
whereas Nav1.6 channels are mainly located at the distal
part of the AIS of both types of interneurons (Li et al.,
2014b). Such differences in the distribution of specific
Nav channel subtypes appear to explain their differential
role in controlling intrinsic excitability of distinct neuronal
populations.
A large number of genetic diseases are caused by mutations in
VGNCs, including inherited forms of periodic paralysis, cardiac
arrhythmia, epilepsy, and chronic pain (Lehmann-Horn and
Jurkat-Rott, 1999; Catterall et al., 2008). Among these, the genes
most frequently associated with inherited forms of neurological
disorders encode for brain Na+ channels Nav1.1 (SCN1A) and
Nav1.2 (SCN2A).
Nav1.1 and Epilepsy
Mutations in SCN1A (Nav1.1) are responsible for genetic epilepsy
syndromes with a wide range of severity. In fact, SCN1A-
associated epilepsies range from simple febrile seizures, to
Generalized Epilepsy with Febrile Seizures (GEFS+; OMIM
604233; Escayg et al., 2000), an autosomal dominant epilepsy
disorder associated to missense mutations, to Severe Myoclonic
Epilepsy of Infancy (SMEI or Dravet syndrome, OMIM 607208;
Dravet et al., 1992; Engel and International League Against
Epilepsy [ILAE], 2001), a much more severe form of epilepsy
often caused by mutations causing truncation or deletions of
Nav1.1 channels. SMEI is a drug-resistant epilepsy occurring in
the first year of life with seizures often associated with elevated
body temperature and progressing to prolonged, clustered, or
continuous seizures and to status epilepticus (Dravet et al., 1992;
Engel and International League Against Epilepsy [ILAE], 2001).
Although only few of the Nav1.1 mutations responsible
for epileptogenic diseases in humans have been functionally
characterized, several evidence point to a loss-of-function as their
common effect (Bechi et al., 2015), with a correlation between
the increasing functional severity of Nav1.1 channel alteration
and the worsening of the clinical phenotype (Catterall et al.,
2010). In other words, missense mutations found in patients with
more benign clinical courses cause milder channel dysfunction,
whereas more dramatic functional consequences are caused
by truncation or loss-of-function mutations described in more
severe phenotypes. Disease-causing Nav1.1 mutations appear to
be spread along the α subunit sequence, with 25% of those
(157/675) affecting the VSM.2 However, other studies (Kanai
et al., 2004) have reported the occurrence of Nav1.1 missense
mutations in SMEI affecting the PM, suggesting that, beside
the type of mutations, also their localization plays a part in the
expressed phenotype. Finally, in some cases mutations of the
same residue, but introducing different amino acids, have been
identified in patients with SMEI (R1648C) or GEFS+ (R1648H;
see below), suggesting that the specific structural and functional
changes prompted by each mutation are strictly related to the
severity of the disease. One of the possible molecular mechanism
2http://www.molgen.ua.ac.be/SCN1AMutations/home/Default.cfm
responsible for the loss-of-function occurring in Nav1.1 disease-
causing mutations is a folding defect, whereby the quality control
system of the endoplasmic reticulum recognizes the mutation-
induced structural defect and targets the abnormal protein
to degradation, severely impeding its membrane trafficking.
Therefore, rescuing defective proteins from degradation appears
as an attractive intervention strategy in Nav1.1-related disease.
Among the various strategies to reverse Nav1.1 folding defects,
co-expression of β1 subunits (Sugiura et al., 2012), exposure to
(lower) temperatures which facilitate correct folding (Bernier
et al., 2004; Rusconi et al., 2007), co-expression with modulatory
proteins (such as calmodulin; Rusconi et al., 2007), as well
as the exposure to Nav blockers (such as phenytoin; Bechi
et al., 2015), are the most studied. In fact, the function of the
epileptogenic missense mutations, including the R859C affecting
the first arginine residue in the DII-S4, can be rescued by co-
expression of the β1 subunit, of the interacting protein ankyrin,
and of a modified scorpion toxin binding to the VSM of
these channels specifically engineered to target the endoplasmic
reticulum (Bechi et al., 2015). Notably, some Nav1.1 mutations
identified in patients affected with GEFS+ or SMEI introduce
different substitutions at the same residue; in these cases, the
extent of the folding defect appears to correlate with disease
severity.
As previously indicated, more than half of the SMEI
mutations cause loss-of-function effects due to stop codons
or deletions, demonstrating that haploinsufficiency of SCN1A
is pathogenic. To understand this counterintuitive result, as
reduced Na+ currents should lead to hypoexcitability rather
than hyperexcitability, mouse models were generated by targeted
deletion in SCN1A gene: notably, the loss of Nav1.1 channels
substantially reduced Na+ currents only in hippocampal
inhibitory interneurons of both Nav1.1+/− and Nav1.1−/− mice,
but not in excitatory pyramidal neurons (Yu et al., 2006;
Ogiwara et al., 2007), therefore causing a loss of sustained
high-frequency firing in hippocampal and cortical interneurons,
possibly explaining the hyperexcitability observed in patients
affected by SMEI.
Alterations of GABAergic interneurons in Nav1.1−/− mice
could also contribute to explain additional clinical manifestations
occurring in SMEI patients: in fact, Nav1.1+/− mice have a
reduced non-REM sleep, impaired circadian behavior, cognitive
impairment and autistic-like traits, reminiscent of those observed
in children with SMEI (Han et al., 2012).
Although the functional consequences of SMEI-associated
mutations are generally recapitulated in SCN1A knockout mice,
functional studies in heterologous expression systems of Nav1.1
channels incorporating GEFS+-associated mutations suggest
that both loss- and gain-of-function effects may contribute to the
pathogenesis of this disease. In particular, functional studies in
an animal model of GEFS+ incorporating the R1648H mutation
affecting the S4 in domain IV of Nav1.1 channels (Figure 3;
Tang et al., 2009; Martin et al., 2010) have suggested that
this variant reduced currents in both excitatory and inhibitory
neurons, although in a different way: indeed, this variant reduced
peak Na+ currents and enhanced slow inactivation in inhibitory
neurons (possibly leading to hypoexcitability of inhibitory
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 July 2015 | Volume 9 | Article 259
Miceli et al. Voltage-sensing module and channelopathies
neurons), whereas it negatively shifted the voltage dependence
of fast inactivation in excitatory neurons (possibly leading to
hyperexcitability of excitatory neurons). As similarly observed
for SMEI-model mice, the combination of these twomechanisms
lead to a predominant reduction in vivo of GABAergic neurons
excitability, therefore explaining the hyperexcitability observed
in GEFS+-affected patients. More recently, a comprehensive
neurophysiological analysis of this mouse model has confirmed
that the R1648H mutation reduces firing in inhibitory neurons
from various brain regions, but does not affect excitability of
excitatory neurons (Hedrich et al., 2014).
Nav1.1 Channels and Familial Hemiplegic Migraine
(FHM3)
Familial Hemiplegic Migraine (FHM) is a rare, monogenic
subtype of migraine with aura, associated to mutations in
three genes. In particular, FHM1 (OMIM 141500) is caused
by mutations in the CACNA1A calcium channel subunit (see
below), FHM2 is caused by mutations in the α2 subunit of the
Na, K-ATPase pump (ATP1A2; OMIM 602481), and FHM3
has been more recently associated to mutations in Nav1.1
channels (de Vries et al., 2009; OMIM 609634). All these
proteins are crucial regulators of ion fluxes across neuronal
and glial cell membranes, suggesting that FHM, and possibly
other forms of migraine, should be considered as cerebral
ionopathies.
So far, only six FHM3-causingmutations have been identified:
one of them (L1649Q) affects the DIV-S4 segment at the
level of a residue following R1648, which is mutated both
in SMEI- or GEFS+-affected patients. Other FHM3-causing
mutations are present in the pore (L263V) or in the DIII-DIV
linker (Q1489K/H and F1499L). Finally, one mutation in the
intracellular DII-DIII linker (T1174S) has been recently found
in a family affected by FHM and epilepsy. Complex alterations
prompted by this mutation on the functional properties of
Nav1.1 channels, including loss- (such as a rightward shift in the
activation curve and a slower recovery from fast inactivation) and
gain- (increased persistent sodium currents, INaP) of-function
mechanisms each appear to be involved in the proepiletogenic
and pro-FHMmanifestations of the disease, respectively (Cestèle
et al., 2013a).
The functional consequences prompted by the VSM-affecting
mutation L1649Q were first assessed by introducing this
mutation in the highly homologous human Nav1.5 (encoded
by the SCN5A gene), revealing a slower inactivation and a
faster recovery from inactivation, predicting enhanced neuronal
excitation (Vanmolkot et al., 2007). However, a subsequent
study, in which this mutation was introduced in Nav1.1 channels
and co-expressed with both human β1 and β2 accessory subunits
(Kahlig et al., 2008), revealed a complete loss of function,
possibly because of a markedly reduced membrane expression of
Nav1.1-L1649Q mutant channels. Notably, a subsequent paper
has demonstrated that the exposure of transfected cells to
permissive temperature (30◦C for 36–48 h) before recordings,
as well as the expression of this mutant in neurons at
physiological temperature (37◦C), was able to partially restore the
function of Nav1.1-L1649Q channels, which therefore behaved
like folding defective mutants; strikingly, rescued currents
showed altered biophysical properties consistent with gain-of-
function effects on neuronal hyperexcitability (Cestèle et al.,
2013b).
Gain-of-function effects are also caused by the pore-
affecting mutation L263V (Kahlig et al., 2008); by contrast,
the Q1489K mutation appears to be associated to complex
functional alterations, particularly in the inactivation process,
leading to predominant loss-of-function effects when expressed
in Nav1.5 (Vanmolkot et al., 2007) or in the long isoform
of Nav1.1 (Kahlig et al., 2008) channels, rather than to
predominant gain-of-function when introduced in the shorter
isoform of Nav1.1 (the predominant variant expressed in
the brain; Schaller et al., 1992) and studied by transfections
of heterologous cells or cultured neurons (Cestèle et al.,
2008).
Two additional Nav1.1 mutations not affecting the VSM
but rather the DIII-DIV linker (Q1498H and F1499L) can also
cause Elicited Repetitive Daily Blindness (ERDB), suggesting
that SCN1A mutations can cause a complex spectrum of human
disease, including epilepsy, FHM3 and/or retinal cell excitability
(Vahedi et al., 2009).
Nav1.2 and Benign Familial Neonatal-Infantile
Seizures (BFNIS)
Benign Familial Neonatal-Infantile Seizures (BFNIS or BFIS3;
OMIM 607745) is a mild seizure syndrome caused by dominant
mutations in SCN2A encoding for Nav1.2 channels (Heron
et al., 2002). Affected individuals have seizures starting in early
infancy (Berkovic et al., 2004). Typically, ictal episodes begin
as partial seizures, which often become generalized. Febrile
seizures are rare. Fortunately, these seizures favorably respond
to treatment with anti-epileptic drugs, and they generally remit
by 1 year of age. Nav1.2 channels are closely related to Nav1.1
channels in amino acid sequence and in their CNS expression
pattern (Goldin et al., 2000). They are primarily expressed
in unmyelinated axons in adult rodent brain (Westenbroek
et al., 1989), being replaced by Nav1.6 channels during axon
myelination (Rasband, 2010). Nav1.2 expression precedes that
of Nav1.1, also increasing during the first 4 weeks of postnatal
life in rodents (Gordon et al., 1987; Beckh et al., 1989).
The relationship between the functional alterations in Nav1.2
channels and the hyperexcitability of BFNIS is not yet clear, also
because not all BFNIS-causing mutations have been functionally
characterized and because contrasting results have been obtained
in some cases upon expression of the same mutant channels
in different expression systems. However, for many VSM-
affecting mutations, such as R223Q (in the DI-S4) and R1319Q
(DIII-S4) gain-of-function effects have been reported (Sugawara
et al., 2001; Scalmani et al., 2006), through complex biophysical
alterations combining a hyperpolarized shift in the voltage-
dependence of activation and a positive shift in the voltage-
dependence of inactivation: these results suggest an increase
in Na+ channels availability, leading to hyperexcitability. In
addition, a further missense mutation (L1563V, within DIV-
S2) in a specific Nav1.2 splice variant expressed at the neonatal
stage caused a gain-of-function effect (Xu et al., 2007). Notably,
Frontiers in Cellular Neuroscience | www.frontiersin.org 11 July 2015 | Volume 9 | Article 259
Miceli et al. Voltage-sensing module and channelopathies
this neonatal isoform has a more positive voltage-dependence
of activation than the adult one, which may contribute to the
relative hypoexcitability of the neonatal brain; moreover, since
the effect of the mutation was specific for this neonatal variant,
it appears likely that seizure disappearance after the neonatal
period in BFNIS patients carrying this mutation is due to the
switch between the two Nav1.2 isoforms or to the developmental
switch between Nav1.2 and Nav1.6 channels (Liao et al., 2010b).
In addition to BFNIS, de novo dominant mutations in
SCN2A can cause also more severe seizure syndromes (Kamiya
et al., 2004; Ogiwara et al., 2009; Liao et al., 2010a;
EIEE11; OMIM 613721): as recently reviewed (Baasch et al.,
2014), 14 mutations in Nav1.2 appear to relate with BFNIS
and 21 mutations with more severe phenotypes, including
developmental delay and intractable seizures. One of the
functionally characterized mutations affecting the VSM, namely
the de novo E1211K mutation, affecting a highly-conserved
residue in the DIII-S1 and found in a patient affected with
intractable seizures and developmental delay, revealed complex
alterations in the biophysical properties of Nav1.2 channels,
including a hyperpolarization of both the half-activation and
half-inactivation potentials and a delay in the recovery from
inactivation, therefore leading to unpredictable results on
mutation-dependent pathogenetic mechanisms. Intriguingly,
computational modeling approaches such as those in Cestèle
et al. (2013a) could predict the predominant mutation-induced
alteration, therefore allowing a better understanding of the
pathogenetic mechanisms associated to specific disease-causing
mutations.
These results suggest that the spectrum of epilepsies
associated to mutations in Nav1.2 channels may be similar to that
observed for Nav1.1 mutations.
Nav1.3-1.6 Channels and Epilepsy
Recently, pediatric epileptic phenotypes have been also
associated to mutations in other two isoforms of the Nav1
channel family, namely Nav1.3 (SCN3A) and Nav1.6 (SCN8A).
Five missense Nav1.3 mutations have been identified in patients
affected by cryptogenic focal epilepsy, mainly localized in the
pore region, except for the D766N mutation, affecting a highly-
conserved residue in the S2 segment of domain II (Holland
et al., 2008; Vanoye et al., 2013). The characterization of the
functional consequences prompted by these mutations in Nav1.3
channels revealed heterogeneous effects, including smaller
current density, slower activation kinetics, depolarized voltage-
dependence of activation and inactivation (particularly in the
case of the R357Q mutation), or increased persistent currents
(as in the case of the E1111K mutation). However, the presence
of each of these mutations induces a common functional
alteration in Nav1.3 currents, consisting in an increased current
activation in response to depolarizing voltage ramps, which
could contribute to neuronal hyperexcitability (Vanoye et al.,
2013).
In addition, mutations in SCN8A have been recently identified
in patients affected with epilepsy and/or intellectual disability
(Larsen et al., 2015; Epileptic Encephalopathy-13, EIEE13;
OMIM 614558). The role of this channel in neuronal excitability
has been firmly assessed by numerous studies in animal models
expressing diverse null SCN8 variants and revealing that a
reduced expression of SCN8A-encoded Nav1.6 channels protects
against seizures by decreasing neuronal excitability (O’Brien and
Meisler, 2013). After the identification of the first mutation
in the pore of Nav1.6 channels in a patient affected with a
severe EE (N1768D; Veeramah et al., 2012), other mutations
have been identified also in the VSM (R223G in the DI-S4,
T767I in DII-S1, and others; Estacion et al., 2014; de Kovel
et al., 2014; Blanchard et al., 2015; Kong et al., 2015). The
functional properties of these mutant channels include both
loss- and gain-of-function characteristics, revealing also in this
case complex pathogenetic mechanisms underlying these severe
phenotypes.
Nav1.7, 1.8, and 1.9 and Pain Disorders
Human genetic studies have clearly revealed a central role for
Nav1.7, Nav1.8, and Nav1.9 Na+ channels in nociception. In fact,
mutations in SCN9A (encoding for Nav1.7), SCN10A (encoding
for Nav1.8) or SCN11A (encoding for Nav1.9) occur in many
human disorders characterized by an altered pain sensation.
SCN9A mutations have been found in families affected by
excruciating pain syndromes including Primary Erythermalgia
(PE; OMIM 133020), Paroxysmal Extreme Pain Disorder (PEPD;
OMIM 167400), or small-fiber neuropathy (OMIM 133020),
as well as by Congenital Insensitivity to Pain (CIP; OMIM
243000), an autosomal recessive disorder in which patients are
insensitive to pain caused by fractures, burns, dental extractions,
and childbirth. Functional characterization of PE-, PEPD- or
neuropathy-causing mutations (often occurring in the VSM, as
in the case of W1538R in DIV-S2 and L823R in DII-S4; Lampert
et al., 2009; Cregg et al., 2013) revealed gain-of-function effects
through different mechanisms (including hyperpolarization in
the activation voltage, slowing of the deactivation, increased
current size, or impairment of channel inactivation). On the
other hand, loss-of-function coding or splicing mutations in
SCN9A leading to a substantial impairment in dorsal root
ganglion (DRG) AP firing have been found in CIP families (Cox
et al., 2006).
A wide genetic screen in patients with small-fiber neuropathy
and negative for SCN9A mutations identified seven disease-
causing variants in SCN10A (Familial Episodic Pain Syndrome,
FEPS2; OMIM 615551). The functional consequences prompted
by these mutations have been assessed only for some of
them, revealing gain-of-function effects on Nav1.8 currents, and
hyperexcitability of DRG neurons. None of these mutations has
been found to affect the VSM (Faber et al., 2012; Huang et al.,
2013; Han et al., 2014).
Other cohorts of patients affected by episodic pain or
by small-fiber neuropathy have been also reported to carry
mutations in the SCN11A gene (Familial Episodic Pain Syndrome
type 3, FEPS3; OMIM 615552). Some of these mutations, which
also affect the voltage sensing modules, increased Nav1.9 current
density and enhanced excitability of DRG neurons (Zhang et al.,
2013; Huang et al., 2014). On the other hand, a different
mutation in SCN11A has been also identified in individuals
with congenital inability to experience pain who suffer from
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recurrent tissue damage and severe mutilations (Leipold et al.,
2013; Hereditary Sensory and Autonomic Neuropathy type 7,
HSAN7; OMIM 615548). This mutation strongly hyperpolarized
the voltage-dependence of Nav1.9 current activation (a gain-of-
function change), while reducing the excitability of DRG neurons
expressing the mutant channel (a loss-of-function at the cellular
level). The enhanced activity of Nav1.9 channels is believed to
lead to an inhibition of neuronal firing of DRGs because of a
strong depolarization of the RMP which impairs transmission
from presynaptic afferents to postsynaptic cells within the spinal
cord, thereby producing pain insensitivity (Waxman et al.,
2014).
Calcium Channelopathies
Structure and Function of Voltage-Gated Calcium
Channels (VGCCs)
VGCCs are involved in a wide range of physiological processes,
such as muscle contraction, neurotransmitter release, hormone
secretion and gene expression. According to their threshold
of activation, VGCCs are classified in two major categories:
low voltage-activated (LVA) and high voltage-activated
(HVA). Structurally, HVA are heteromultimeric protein
complexes formed by co-assembling of a pore forming α1
subunit and α2, δ, β, γ ancillary subunits (Figure 1); by
contrast, LVA channels appear to lack ancillary subunits
(Catterall et al., 2005). There are three major families of Cav α1
subunits, namely Cav1, Cav2 and Cav3, each including several
members: based on their biophysical and pharmacological
features, HVA channels include Cav1 (encoding for L-type
channels) and Cav2 (encoding for P/Q-, N- or R-type
channels) families, whereas LVA channels comprise the
Cav3 family (encoding for T-type channels). The Cav1
channel family encodes three different neuronal L-type
channels (called Cav1.2, Cav1.3, and Cav1.4), in addition to
a skeletal muscle-specific isoform Cav1.1 channel; the Cav2
channel family includes three members (Cav2.1, Cav2.2,
and Cav2.3); among them, Cav2.1 channels gives rise to P-
or Q-type channels by alternative splicing and assembly
with specific ancillary subunits; Cav2.2 encodes for N-type
channels and Cav2.3 for R-type channels. Cav3 channel
family includes three members (Cav3.1, Cav3.2 and Cav3.3),
corresponding to T-type calcium channels (Simms and Zamponi,
2014).
So far, several human disorders have been linked to mutations
in VGCCs affecting the skeletal muscle and the nervous system.
In particular, mutations in Cav1.2 are associated to Timothy
Syndrome (TS), characterized by severe arrhythmia and multiple
organ systems dysfunctions, including neurological disorders
such as autism and mental retardation. By contrast, mutations
in Cav3.2 channels have been found in various forms of
idiopathic generalized epilepsies: disease-associated mutations
prompted gain-of-function effects, leading to an increased
neuronal excitability and changes in gene transcription (Eckle
et al., 2014). To the best of our knowledge, no TS- or epilepsy-
causing mutations in Cav1.2 or Cav3.2 genes, respectively, has
been found to affect the VSM; thus, these mutations will not
be further addressed in the present manuscript. By contrast,
mutations in Cav2.1 are associated to migraine (FHM1) and
ataxias (EA2 and SCA6); since mutations in Cav2.1 often affect
the VSM, these diseases will be discussed in the following
section.
Cav2.1 Mutations Linked to Familial Hemiplegic
Migraine Type 1 (FHM1), Episodic Ataxia Type 2 (EA2)
and Spinocerebellar Ataxia Type 6 (SCA6)
Cav2.1 channels are predominantly expressed in neuronal
and neuroendocrine cells, where they play a crucial role in
neurotransmitter release, particularly at excitatory synapses
(Westenbroek et al., 1995). Based on their expression in
areas involved in migraine and/or migraine pain pathogenesis,
including the cerebral cortex, the trigeminal ganglia, and
brainstem nuclei, as well as the cerebellum, it is not surprising
that mutations in the CACNA1A gene encoding for Cav2.1
have been linked to neurological disorders, such as Familial
Hemiplegic Migraine type 1 (FHM1; OMIM 141500), Episodic
Ataxia type 2 (EA2; OMIM 108500) and Spinocerebellar
Ataxia type 6 (SCA6; OMIM 183086); patients carrying Cav2.1
mutations often present significant overlapping symptoms,
suggesting shared pathophysiological mechanisms (Pietrobon,
2013). As previously described for FHM3, FHM1 is a
rare, autosomal dominant form of migraine with aura,
characterized by recurrent attacks of disabling headache and,
in some cases, progressive cerebellar atrophy. So far, 25
mutations in Cav2.1 have been found in FHM1-affected
patients (de Vries et al., 2009; Pietrobon, 2013), mostly
affecting the pore and the VSM (Figure 3). Functional
expression in heterologous systems revealed that a common
functional effect of FHM1 mutations is a shift in the
activation curve toward hyperpolarized voltages, thus increasing
Cav2.1 open probability and leading to gain-of-function
effects (Tottene et al., 2002). In particular, the functional
effects of the VSM-affecting R192Q mutation have been
studied in a knock-in mouse model: electrophysiological
recordings from cerebellar granule cells of this mouse showed
an increase in Cav2.1 current density, a hyperpolarizing
shift in the voltage-dependence of current activation, an
increase in calcitonin gene-related peptide (CGRP) release
and increased susceptibility to cortical spreading depression
(Tottene et al., 2009), a mechanism that is believed to cause
the migraine-preceding aura (Lauritzen, 1994). R192Q-induced
gain-of-function of Cav2.1 channels appears also responsible
for a larger AP-evoked calcium current and a longer AP
duration in Capsaicin-Insensitive Trigeminal ganglion neurons
(CI-T) when compared to CI-T neurons from WT mice
(Fioretti et al., 2011). These effects appear rather specific for
glutamatergic neurons, as also the probability of glutamate
release appears enhanced in Cav2.1-R192Q expressing neurons
(Tottene et al., 2009) when compared to wild-type neurons,
whereas gating properties of the Cav2.1 channels expressed in
GABAergic interneurons are barely affected (Vecchia et al.,
2014).
EA2 is an autosomal dominant, paroxysmal cerebellar
disorder, characterized by ataxia, migraine-like symptoms,
interictal nystagmus and cerebellar atrophy. More than 20
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CACNA1Amutations have been linked to EA2: most of them are
nonsense (Jen et al., 1999) or missense (Guida et al., 2001; Wappl
et al., 2002) mutations. Most nonsense mutations are predicted
to truncate Cav2.1 subunits, resulting in loss-of-function effects;
furthermore, their expression in heterologous systems together
with wild-type channels produces dominant-negative effects
(Jeng et al., 2006). In some cases, generalized epilepsy can also be
found associated with EA2 (Jouvenceau et al., 2001), as reported
for the R1820X nonsense mutation having both loss-of-function
and dominant-negative effects on co-expressed wild-type Cav2.1.
No EA2-causing mutation has been identified in the VSM.
SCA6 is an autosomal dominant, paroxysmal cerebellar
disorder characterized by late-onset, slowly-progressive ataxia
and Purkinje neuron degeneration. This disease is associated
with a different degree of a CAG repeat expansion (20–33
repeats) at the distal C-terminus of Cav2.1 channels (Ishikawa
et al., 1997; Zhuchenko et al., 1997): therefore, also in this case
the VSM is not a hot-spot region for disease-causing mutations.
The VSM as a Molecular Target for Toxins
and Syntetic Compounds
VGICs are molecular targets for several classes of drugs,
including anticonvulsants, antiarrhythmics, and local anesthetic
molecules; most of them recognize a binding site located within
the pore region. More recently, the VSM also emerged as a novel
pharmacological target for some classes of toxins and synthetic
compounds. In VGNCs, three binding sites for neurotoxins
have been identified in the VSM (Catterall et al., 2007). Site 3,
located in the transmembrane loop between DIV-S3 and DIV-S4,
is targeted by several groups of polypeptide toxins: α-scorpion
toxins, sea-anemone toxins, and some spider toxins. These
molecules slow or block Na+ channel inactivation by inhibiting
the conformational changes coupling channel activation to
fast inactivation (Rogers et al., 1996). This mechanism, called
‘‘voltage-sensor trapping’’ (Cestèle et al., 1998), may also describe
the mode of action of other gating modifier toxins. Site 4, located
in the S1–S2 and S3–S4 loops of domain II, is recognized by
β-scorpion toxins. These toxins induce both a negative shift in the
voltage-dependence of Na+ channel activation and a reduction
in the maximal current. Finally, site 6, probably located near
site 3, is occupied by δ-conotoxins that cause a slowing in
Na+ channel inactivation. Toxin-induced sensor-trapping can
also occur in VGCCs (agatoxins from spiders; McDonough,
2007), and in VGKCs of the Kv2 and Kv4 (hanatoxins from
tarantula; Swartz and MacKinnon, 1997) or Kv3 and Kv11
(sea anemone toxins; Diochot and Lazdunski, 2009) subclasses.
More recently, a novel molecular variant of AaTXKβ, namely
AaTXKβ(2−64), from Androctonus australis scorpion venom has
been shown to cause a hyperpolarization shift in the voltage-
dependence of activation of Kv7.4 channels (Landoulsi et al.,
2013) with a mechanism reminiscent of that described for β-
scorpion toxins acting at site 4 of VGNCs (Dutertre and Lewis,
2010).
Besides toxins, also synthetic compounds may recognize a
binding site located within the VSM; this pharmacological action
has been exploited in some VGNCs and, among VGKCs, in the
Kv7 subfamily. In fact, two compounds (ICA-121431 and PF-
04856264) selectively inhibit currents from Nav1.1/Nav1.3 and
Nav1.7 channels, respectively, by interacting with a site located at
the extracellular ends of the S2 and S3 transmembrane segments
of domain IV, a region that overlaps with the interaction sites for
some scorpion and anemone toxins (McCormack et al., 2013).
An analog of the analgesic drug diclofenac, called NH29, has been
demonstrated to interact with an external groove formed by the
interface of S1, S2, and S4 helices of the VSM in Kv7.2 channels,
where it stabilizes the interaction between two conserved residues
in S2 (E130) and S4 (R207). This compound shifts toward the left
the activation curve and increases the maximal current of Kv7.2
channels, thereby acting as a non-toxin gating modifier (Peretz
et al., 2010). By contrast, another anolog of diclofenac, called
NH17, is able to block Kv7.2 channels recognizing a binding site
in the VSM. Intriguingly, both compounds, NH17 and NH29,
bind to the VSM of transient receptor potential vanilloid 1
(TRPV1) channels exerting opposite effects: indeed, they act as
an activator and a blocker of TRPV1 currents, respectively. These
two compounds also recognize a binding site in the VSM of the
proton channel mVSOP (Kornilov et al., 2014). In addition, also
another Kv7.2/3 channel opener, referred as ICA-27243, seems
to interact with the VSM (Wickenden et al., 2008), although
the specific amino acids involved in drug binding have not
been yet identified (Padilla et al., 2009). The compound ztz240,
discovered by a screening of 20,000 compounds using rubidium
flux combined with atomic absorption spectrometry, increases
Kv7.2 currents by interacting with the F137 residue in the gating
charge pathway of Kv7.2 channels (Gao et al., 2010; Li et al.,
2013). Interestingly, the same phenylalanine (F137) in the S2 of
Kv7.2 forms the binding site for a previously reported Kv11.1
activator, NS1643, which also causes a leftward shift in current
activation and slows current deactivation of Kv7.2 channels (Li
et al., 2014a).
Conclusion
Although the general principles of voltage-sensing have been
described by purely functional experiments well over 50 years
ago, recent progress in apparently distinct fields of investigation
ranging from molecular genetics to X-ray crystallography have
contributed to the identification of human diseases caused by
altered gating of a large number of VGICs, and to the description
of the intimate molecular mechanisms of this process at nearly
atomic level resolution. In the present work, we have described
the diseases associated with mutations in the VSM of neuronal
voltage-dependent K+, Na+, and Ca2+ channels, at the same
time reporting on the described functional consequences of
some of these disease-causing mutations and on the potential
pathogenetic mechanisms. In addition, it should be underlined
that the study of the functional consequences of naturally-
occurring mutations, beside unraveling the potential disease
pathogenetic mechanisms, provide unique opportunities to
refine our current view of the role played by specific amino
acids in channel function; as an example, the opposite functional
behavior shown by Kv7.2 mutations affecting the distal end of S4
(causing a marked rightward shift in gating) when compared to
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those in the proximal end of the same transmembrane segment
(which, instead, caused a negative gating shift), provides strong
support to the current view of the molecular motions occurring
in S4 during voltage-dependent gating. By this effort, we took
the opportunity to highlight some of the major controversies
and pressing issues in the field. Most channelopathies herein
described have quite high penetrance and recognize the genetic
mutations as a critical event in disease etiology; therefore,
whenever possible, we have attempted to highlight genotype-
phenotype correlations emerging from the detailed study of the
extent of functional derangements found in most commonly
used experimental systems. In an era of fast-advancing genomic
techniques which allow the identification of a large number
of variants in ion channel genes in several human diseases,
such studies may contribute to a better definition of genotype-
phenotype correlations, assisting in the definition of disease-
based criteria to score variant severity, predict their pathogenetic
role, and formulate prognostic hypotheses. Such efforts are likely
to provide critical data which will be fed into current efforts
to standardize and provide guidelines for the interpretation
of sequence variants such as those recently provided by the
American College of Medical Genetics and Genomics and
the Association for Molecular Pathology (Richards et al.,
2015). Curation tools such as ClinGen3 or ClinVar,4 will be
instrumental in the interpretation of the association between
variants and genetic diseases, and are also likely to standardize
3http://clinicalgenome.org/
4http://www.ncbi.nlm.nih.gov/clinvar/
phenotyping routines which may result in a more in-depth
disease classification. Another crucial issue is the need for
better experimental tools (cellular and animal models) to
investigate the mechanism(s) by which each specific variant
contributes to disease pathogenesis; similar clinical courses are
apparently associated with both loss- and gain-of-function effects
by specific ion channel variants, highlighting our rudimentary
understanding of the molecular steps involved. Finally, given that
the subtle structural transitions occurring during gating are likely
specific and distinct for each ion channel family and subfamily,
we also believe that the VSM is an underestimated target for
drug action; we envision that an improved structural knowledge
of channel gating may lead to the design of drugs effective on
specific VSM states, thereby allowing patient-tailored therapies
for rare diseases caused by each VSMmutation. Such drugs could
be also of great therapeutic benefit for more common disorders
involving changes in ion channel gating.
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